GL1X · GenesisL1 explorer

MolNFT v1 · #105168 · protein

Ycp BETA5-A50V mutant in complex with carfilzomib

4QWL · Proteasome subunit alpha type-2: “Ycp BETA5-A50V mutant in complex with carfilzomib”. X-ray diffraction, 3 ligands (3BV, MG, CL), 20 pockets (best druggability 0.84). MolNFT v1 #105168 on GenesisL1: 3D structure, binding sites and…

PDB
4QWL
Type
protein
Length
6,336 residues
Chains
28
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proteasome subunit alpha type-2; Proteasome subunit alpha type-3; Proteasome subunit…
UniProt
P23639, P23638, P40303, P32379, P40302, P21242, P21243, P25043, P25451, P22141, P30656, P23724, P30657, P38624
Ligands
3BV, MG, CL
Pockets
20 · best druggability 0.84

Structure

x-ray diffraction · 14 distinct chains · 36% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, OProteasome subunit alpha type-2protein25036% helix, 25% strandP23639
B, PProteasome subunit alpha type-3protein24438% helix, 25% strandP23638
C, QProteasome subunit alpha type-4protein24036% helix, 23% strandP40303
D, RProteasome subunit alpha type-5protein23539% helix, 27% strandP32379
E, SProteasome subunit alpha type-6protein23137% helix, 28% strandP40302
F, TProbable proteasome subunit alpha type-7protein24340% helix, 26% strandP21242
G, UProteasome subunit alpha type-1protein24142% helix, 23% strandP21243
H, VProteasome subunit beta type-2protein22229% helix, 35% strandP25043
I, WProteasome subunit beta type-3protein20432% helix, 33% strandP25451
J, XProteasome subunit beta type-4protein19534% helix, 34% strandP22141
K, YProteasome subunit beta type-5protein21236% helix, 35% strandP30656
L, ZProteasome subunit beta type-6protein22229% helix, 31% strandP23724
M, aProteasome subunit beta type-7protein23331% helix, 31% strandP30657
N, bProteasome subunit beta type-1protein19636% helix, 34% strandP38624

Ligands and binding sites

  • 3BV · N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide · ligand · 6 copies · chains H, I, K, L, N, V, W, Y, Z, b
  • MG · Magnesium ion · metal · 8 copies · chains G, I, K, W, N, a, H, L, V, Y, Z
  • CL · Chloride ion · ion · 4 copies · chains G, H, N, U, V, b
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · 2 copies · chains K, X, Y

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111880.840.851683BV
210650.830.84158empty
310170.790.8199empty
410210.780.80124empty
57600.780.8297empty

Interfaces

92 interfaces between chains.

  • H–I · 1729 Ų buried · 27 hydrogen bonds · protein-protein
  • V–W · 1726 Ų buried · 27 hydrogen bonds · protein-protein
  • B–C · 1569 Ų buried · 23 hydrogen bonds · protein-protein
  • P–Q · 1540 Ų buried · 20 hydrogen bonds · protein-protein
  • H–Z · 1477 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 covalent (covalent ligand).

Compared structures

  • 4QWL · yCP beta5-A50V mutant in complex with carfilzomib · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.